Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

NCT02389543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated this trial and added a Lenalidomide arm to KCP-330-017

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Karyopharm Therapeutics Inc